Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

miRNAs and Target Genes in Breast Cancer MetastasisMolecular Pathogenesis of Breast Cancer and the Role of MicroRNAs

miRNAs and Target Genes in Breast Cancer Metastasis: Molecular Pathogenesis of Breast Cancer and... [Breast cancer is a leading cause of cancer-associated death in women worldwide. The therapy usually involves mastectomy or lumpectomy, followed by chemotherapy and/or radiation therapy in addition to hormonal therapy when indicated. While the area of research on the identification and potential use of microRNAs (miRNAs) as either a diagnostic, prognostic, or predictive biomarker is still in its early stages, there is increasing evidence that miRNAs are involved in tumor progression, chemoresistance, and survival. The miRNAs have enormous prospective in clinical research since they are detected in the serum, plasma, fresh tissues, and formalin-fixed paraffin-embedded tissue samples. Hence, it may be possible to develop novel therapeutic regimens of specific miRNAs as targets to prevent or treat breast cancer (BC). The miRNA expression profiling is now used extensively by many investigators to demonstrate specific miRNA signatures in both the body fluids and in the tumor tissue, indicating that miRNAs may likely be useful as diagnostic and prognostic tools in all cancers including BC. Numerous investigators, including our laboratory, have used strategies to deregulate miRNAs with either anti- and pre-miRNA molecular drugs or even natural compounds to prevent or control tumor progression, which will be discussed in this chapter. Moreover, the role of several natural and synthetic compounds as anticancer agents will also be discussed in this chapter. Finally, the role of several miRNAs as targets will be discussed especially because miRNA-based therapies are currently being exploited for cancer therapy.] http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png

miRNAs and Target Genes in Breast Cancer MetastasisMolecular Pathogenesis of Breast Cancer and the Role of MicroRNAs

Download PDF
16 pages

Loading next page...
 
/lp/springer-journals/mirnas-and-target-genes-in-breast-cancer-metastasis-molecular-00NoGyxa3L

References (81)

Publisher
Springer International Publishing
Copyright
© Springer International Publishing Switzerland 2014
ISBN
978-3-319-08161-8
Pages
7 –22
DOI
10.1007/978-3-319-08162-5_2
Publisher site
See Chapter on Publisher Site

Abstract

[Breast cancer is a leading cause of cancer-associated death in women worldwide. The therapy usually involves mastectomy or lumpectomy, followed by chemotherapy and/or radiation therapy in addition to hormonal therapy when indicated. While the area of research on the identification and potential use of microRNAs (miRNAs) as either a diagnostic, prognostic, or predictive biomarker is still in its early stages, there is increasing evidence that miRNAs are involved in tumor progression, chemoresistance, and survival. The miRNAs have enormous prospective in clinical research since they are detected in the serum, plasma, fresh tissues, and formalin-fixed paraffin-embedded tissue samples. Hence, it may be possible to develop novel therapeutic regimens of specific miRNAs as targets to prevent or treat breast cancer (BC). The miRNA expression profiling is now used extensively by many investigators to demonstrate specific miRNA signatures in both the body fluids and in the tumor tissue, indicating that miRNAs may likely be useful as diagnostic and prognostic tools in all cancers including BC. Numerous investigators, including our laboratory, have used strategies to deregulate miRNAs with either anti- and pre-miRNA molecular drugs or even natural compounds to prevent or control tumor progression, which will be discussed in this chapter. Moreover, the role of several natural and synthetic compounds as anticancer agents will also be discussed in this chapter. Finally, the role of several miRNAs as targets will be discussed especially because miRNA-based therapies are currently being exploited for cancer therapy.]

Published: Sep 6, 2014

Keywords: Breast cancer; Serum; FFPE; miR-21; miR-125; miR-34a; miR-200; miR-155; miR-10b; Plumbagin; Garcinol; Curcumin

There are no references for this article.